Researchers Develop Nose-Spray Vaccine to Combat Drug-Resistant Tuberculosis
Photo: CDC / Unsplash
Johns Hopkins Medicine scientists have created an innovative nasal vaccine that trains the immune system to fight tuberculosis bacteria that survive standard antibiotic treatment. By combining two TB genes, this therapeutic approach offers new hope against a disease that remains the world's leading infectious cause of death. The breakthrough could transform how we tackle one of global health's most persistent challenges.
Johns Hopkins Medicine scientists have created an innovative nasal vaccine that trains the immune system to fight tuberculosis bacteria that survive standard antibiotic treatment. By combining two TB genes, this therapeutic approach offers new hope against a disease that remains the world’s leading infectious cause of death. The breakthrough could transform how we tackle one of global health’s most persistent challenges.